Yes nothing new...
but the abstract does not show the change in eGFR. In the clinical trials document, Secondary Outcomes Measures #12 is the change in eGFR in the < 60 cohort. That is what we are missing. Hopefully that is what they show at the presentation. If not, then who knows?
abstract is on page 181 or 182....took me a long time scrolling through...started from the bottom